Cellular consequences of stress and depression by Fuchs, Eberhard & Flügge, Gabriele
tressful life events are among the most potent
factors that trigger or induce depressive episodes in
humans.The brain responds to stress experiences in a
complex manner related to the activation and inhibition
of neurons that are involved in sensory, motor, auto-
nomic, cognitive, and emotional processes. Chronic
stress, which is known to be accompanied by hyperac-
tivity in central nervous neurotransmitter systems,
induces cellular changes that can be regarded as a form
of plasticity.This causes mood alterations in the affected
individual and has the potential to reverse the psy-
chopathological processes,thus alleviating the symptoms
of depression. Since social stress in animals evokes
symptoms that resemble those found in depressed
patients, chronic social stress can serve as an experi-
mental paradigm to investigate the neuronal processes
that may also occur during depressive disease in humans.
Research over past years has led to considerable
advances in the understanding of the neural causes of
depression and the cellular mechanisms that underlie the
beneficial effects of currently available antidepressants.
More importantly,such research forms the basis for the
future development of more effective antidepressant
drugs.
Stress changes the activity of noradrenergic
and adrenergic neurons
Stress is known to activate neurohormonal systems,such
as the hypothalamo-pituitary-adrenal (HPA) axis, to
release the central nervous “stress peptide” corti-
cotropin-releasing factor,
1 and to secrete glucocorticoids
from the adrenal gland.
2These corticosteroids have been
identified as prominent factors that modify metabolic
processes in both the body and the brain during stress as
well as depression.
3 However,the other group of essen-
tial substances in basic and accelerated metabolism
includes the monoamines, noradrenaline, adrenaline,
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Stress is known to activate distinct neuronal circuits in
the brain and induce multiple changes on the cellular
level, including alterations in neuronal structures. On the
basis of clinical observations that stress often precipitates
a depressive disease, chronic psychosocial stress serves as
an experimental model to evaluate the cellular and mol-
ecular alterations associated with the consequences of
major depression. Antidepressants are presently believed
to exert their primary biochemical effects by readjusting
aberrant intrasynaptic concentrations of neurotransmit-
ters, such as serotonin or noradrenaline, suggesting that
imbalances within the monoaminergic systems con-
tribute to the disorder (monoaminergic hypothesis of
depression). Here, we review the results that comprise
our understanding of stressful experience on cellular
processes, with particular focus on the monoaminergic
systems and structural changes within brain target areas
of monoaminergic neurons.  
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(e-mail: efuchs@gwdg.de)dopamine,serotonin (5-hydroxytryptamine [5-HT]),and
histamine. The present survey focuses on processes
related to stress-mediated activation of monoaminergic
neurons in the brain.
The noradrenergic and adrenergic neurons are located in
the brain stem,where they form groups of cells that pro-
ject axons to many parts of the brain. The best-
studied group of noradrenergic neurons, located in the
pontine locus ceruleus (LC), innervate several brain
regions including the neocortex and the limbic system.
The limbic system is a collection of regions that appear to
regulate emotional processes (Figure 1).The noradrener-
gic LC neurons play an important role in the regulation
of mood and emotions as well as of attention span.
When stimulated through stressful challenge,for exam-
ple, noradrenaline is released from the nerve terminals
in the target brain region and is bound to adrenergic
receptors belonging to the group of G protein–coupled
receptors (GPCRs).These membrane-bound proteins
convey signals from the extracellular to the intracellular
compartment of a cell (Figure 2). GPCR signaling
requires several steps for transmission of the signal,last-
ing from milliseconds to many minutes.The binding of a
natural agonist such as noradrenaline or adrenaline to
the receptor initiates a cascade of intracellular events
that drive the activity of the cell and involve effectors
such as enzymes (eg, adenylyl cyclase, phospholipase,
kinases, and phosphatases), second messengers (eg,
cyclic adenosine monophosphate [cAMP],cyclic guano-
sine monophosphate [cGMP], calcium ions, and arachi-
donic acid),as well as ion channels,which modulate the
electrical activity of the neuron. A long-term effect
occurring minutes after binding GPCR is the regulation
of gene transcription and subsequent protein synthesis
(Figure 2).
5 There are different types of adrenergic
receptors in the brain whose activation either stimulates
or inhibits the respective target neurons.Noradrenaline
and adrenaline bind to the same types of adrenergic
receptors,although with slightly different affinities.
6
Various experiments have shown that during stress,
noradrenergic and adrenergic neurons release more
noradrenaline and adrenaline,respectively,and that the
turnover of these neurotransmitters is accelerated so
that their concentrations and/or amounts of their
metabolites fluctuate in relation to the intensity and
duration of the stressor.
7-10 Acute stress induces only a
transient rise in noradrenaline levels, but chronic stress
with recurrent environmental challenges can lead to
repetitive increases in concentration.As a consequence,
adrenoceptors on the surface of the target neurons are
bombarded with noradrenaline, leading to a reduction
in adrenoceptor numbers (receptor downregulation).
11
On the other hand,low concentrations of noradrenaline
induce adrenoceptor upregulation.
12
Changes in α2-ARs alter 
the activity of neurons
The most studied adrenergic receptors,with respect to reg-
ulation in chronic stress, are the α2-adrenoceptors (α2-
ARs),of which three subtypes are known (A,B,and C).
13
Because of their widespread distribution in the brain,α2-
ARs are diversely involved in mediating the analgesic and
sedative effects of agonists such as dexmedetomidine
14 and
in modulating the baroreceptor reflex.
15The involvement
of α2-ARs in the regulation of attention is suggested by the
finding that methylphenidate (the nonamphetamine stim-
ulant used to treat children with attention-deficit hyper-
activity disorder) affects neuronal activity in the LC.
16
Administration of the antagonist yohimbine (a sympa-
tholytic drug that is used to treat impotence) increases fir-
ing of the LC neurons,resulting in anxiety-like behavior
in rats and monkeys.
17 Brain α2-AR changes have been
observed in depressed patients (see below).
The α2A-AR autoreceptor in LC noradrenergic neurons,
regulates noradrenaline release via a negative feedback
loop.
14,18 Expression of this autoreceptor is reduced soon
after the onset of stress (see below).In addition,α2A-AR
is also expressed in neurons that release the excitatory
neurotransmitter glutamate.
19 In general,α2-AR stimu-
lation leads to a transient inhibition of neuronal firing
through hyperpolarization that is related to the modu-
lation of calcium and potassium channels.
20,21 There is
reduced intracellular formation of the second messen-
ger,cAMP,which itself regulates many cellular functions
including gene transcription.
22,23
Different forms of stress, such as immobilization or a
cold environment,alter α2-AR numbers in distinct brain
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Selected abbreviations and acronyms
 2-AR  2-adrenoceptor
 -AR  -adrenoceptor
DAT dopamine transporter
GPCR G protein–coupled receptor
5-HT 5-hydroxytryptamine (serotonin)
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Figure 1. Monoaminergic neurons innervate almost all brain areas. A. Noradrenaline. The noradrenergic neurons of the locus ceruleus project to
the limbic and cortical regions, and to the thalamus, cerebellum, and spinal cord. They play an important role in the regulation of mood
and attention. The noradrenergic neurons of cell groups A1, A2, A5, and A7 project to more restricted regions.
4 They are important for
autonomic function. B. Dopamine. The dopaminergic neurons of the substantia nigra and the adjacent ventral tegmental area (VTA) pro-
ject to the striatum and to regions in the neocortex. They are important in the initiation of movements and for emotional processes.
Furthermore, there is a dopaminergic cell group in the hypothalamus that regulates neuroendocrine processes. C. Serotonin. The sero-
tonergic neurons located in the raphe nuclei project to almost all parts of the brain and are involved in many functions including the reg-
ulation of emotional processes. D. Histamine. Histaminergic neurons are located in the tuberomammillary complex of the hypothalamus.
They project to all parts of the brain and are important for arousal (the excited brain state). Modulation of neuronal activity by these
monoamines is an important factor of well-balanced central nervous activity. Stress leads to hyperactivity of the monoamine neurons and
thus to a dysregulation of neuronal activity. Currently available antidepressants are thought to adjust the balance between the different
neurotransmitter systems.
B. Dopamine
C. Serotonin D. Histamine
A. Noradrenalineregions.
24,25We investigated the consequences of chronic
psychosocial stress using a stress paradigm in male tree
shrews.
26 Our experiments showed that chronic psy-
chosocial stress reduces α2-AR expression in brain
regions that regulate autonomic functions and emotional
behavior.
27This receptor downregulation is most proba-
bly related to the stress-mediated rise in noradrenaline
concentrations. Regulation of noradrenaline release is
impaired soon after the onset of the stress period, as
revealed by reduced expression of the α2A-AR in the
LC.
28 During a stress period lasting several weeks,adren-
ergic regulation changes,giving an initially high level and
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Figure 2. Neurotransmission via a G protein–coupled receptor (GPCR): binding of the neurotransmitter to the receptor initiates a cascade of intra-
cellular events that drive the activity of the neuron or cell. The G-protein complex, consisting of subunits α, β, and γ, serves as the machin-
ery that transduces the extracellular signal to various effectors at the intracellular side of the plasma membrane, to the enzymes adeny-
lyl cyclase or phospholipase. These enzymes catalyze the synthesis of second messengers, such as cyclic adenosine monophosphate (cAMP)
and diacylglycerol, which regulate gene transcription in the nucleus. Transcripts (mRNA) are later translated into protein. Calcium ions
released from intracellular stores and other second messengers activate protein kinases and phosphatases. This leads to phosphorylation
and/or dephosphorylation of many intracellular proteins as well as ion channels that are located in the plasma membrane of the cell.
Phosphorylation/dephosphorylation induces opening and closing of these channels and this modulates the electrical activity of the neu-
ron. These dynamic cellular processes are accelerated during stress when neurotransmitter concentrations are elevated.
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mthen finally a low level of noradrenaline.This is the case
in the prefrontal cortex, a brain area important for the
regulation of mood and behavior.
29 Following a chronic
stress period, noradrenaline concentrations are obvi-
ously low throughout the whole brain, probably due to
a gradually acquired deficit in transmitter synthesis,
transport, and/or release from the noradrenergic neu-
rons.
30 Interestingly, studies on postmortem material
from brains of depressed human patients also revealed
the upregulation of α2-ARs in several brain regions.
31-33
These data therefore support the “noradrenaline deficit
hypothesis,” which assumes there is a reduced nor-
adrenaline concentration in the brains of depressed
patients.
34 Antidepressants that interact with α2-ARs
such as mirtazapine probably counteract this deficit.
35
β-ARs also change during stress
GPCR β-adrenoceptors (β-ARs) increase cAMP syn-
thesis.
36 They are present in neurons and glial cells.
37
When stimulated by agonists (adrenaline or noradrena-
line), β-ARs are rapidly internalized into the cells.
Therefore, high levels of endogenous agonists quickly
reduce numbers of β-AR molecules in the plasma mem-
brane of target cells,inducing desensitization.
11,38 β-ARs
are first internalized into the cell; they undergo intra-
cellular sequestration with subsequent reinsertion into
the plasma membrane, thereby restoring the normal
receptor pattern in the membrane.
β-AR dysfunction is thought to play a role in psychiatric
disorders, and β-AR blockers have been used to treat
depression and anxiety.
39 The number of β1-ARs in the
temporal and frontal cortex of suicide victims has been
found to be significantly lower than in matched con-
trols.
40,41 However,the psychotropic role of β-AR down-
regulation is still under discussion since the antidepres-
sant desmethylimipramine also downregulates brain
β-ARs.
42 On the other hand, the treatment of rats with
the selective serotonin reuptake inhibitors (SSRIs)
citalopram and fluoxetine increased β1-AR radioligand
binding in the frontal cortex and striatum.
43
Stress downregulates β-ARs in the brain.
44 Our data from
the tree shrew chronic stress model reveal that (i) the
effects are dependent on the duration of a stressful event;
(ii) β1- and β2-ARs are differentially regulated;and (iii)
the effects differ in different brain regions.
45 Some of the
stress-induced changes are only transient,since normal
receptor numbers are restored through the reinsertion of
intracellularly sequestered receptor molecules into the
plasma membrane.Finally,after 4 weeks of psychosocial
stress,the number of β1-ARs was decreased in cells of the
hippocampus and parietal cortex.
Stress and 5-HT neurons
It is generally assumed that changes in serotonergic neu-
rons underlie depressive diseases because the most
widely used antidepressants are SSRIs,which raise extra-
cellular levels of 5-HT.Several experimental results have
confirmed the “5-HT deficit hypothesis”of depression.
In mammals, the majority of 5-HT-producing neurons
are located in the brain stem, most of them on or near
the midline,and they innervate almost every area of the
brain.
46 The serotonergic neurons of the dorsal raphe
nucleus that project to the forebrain are autoactive and
discharge in a stereotyped pattern that changes during
the sleep–wake–arousal cycle.
47,48 Due to its wide distri-
bution, it has been suggested that the 5-HT system is
involved in almost every brain function,such as the reg-
ulation of neuroendocrine secretion, regulation of car-
diovascular and respiratory activity, sleep, nociception,
analgesia, and motor output.
49-51 5-HT definitely regu-
lates mood, since its transporters and receptors are tar-
gets for several psychotropic drugs.
52A polymorphism in
the promoter region of the 5-HT transporter (5-HTT)
gene is thought to contribute to anxiety in humans,
53 and
an epidemiological study provides evidence that an
allele encoding a short DNA sequence in this promoter
region increases the risk of developing a depressive dis-
order.
54 Rhesus monkeys with the short-sequence allele
have low concentrations of the 5-HT metabolite 
5-hydroxyindoleacetic acid in their cerebrospinal fluid.
55
This finding agrees with the view that low brain 5-HT
levels (“decreased serotonergic activity”) have negative
effects on emotionality. However, 5-HT concentration
per se is probably not the only trigger for mood changes;
humans with a genotype conferring high levels of
expression of monoamine oxidase A (MAOA, the
enzyme that degrades 5-HT) are less likely to develop
antisocial problems than individuals with lower MAOA
expression.
54
Stress elevates the concentrations of 5-HT and its
metabolites in several brain regions,indicating increased
turnover rates of the neurotransmitter,
8,56 although the
serotonergic neurons of the dorsal raphe nucleus do not
change their discharge rate during stress.
46 Nevertheless,
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targets of the serotonergic neurons, so that repeated
exposure of rats to forced swimming increased 5-HT
concentrations in the striatum, whereas they were
reduced in the lateral septum.
57 Chronic restraint stress
in rats accelerated 5-HT turnover in the hippocampus
and produced low amounts of the monoamine.
58
Many receptors (>14) are known to mediate the effects
of 5-HT.
59 The present survey focuses on the 5-HT1A
receptor, the best characterized 5-HT receptor. This
GPCR inhibits neuronal activity by reducing cAMP for-
mation or phosphoinositide hydrolysis,depending on the
type of neuron where it is expressed, and it modulates
potassium and calcium channels.
60,61The somatodendritic
5-HT1A autoreceptors located on the serotonergic neu-
rons in the raphe nuclei regulate 5-HT release. Post-
synaptic 5-HT1A receptors regulate the activity of neu-
rons in cortical, limbic, and other regions. For example,
they affect the activity of pyramidal neurons in the hip-
pocampus.
62-64
The 5-HT1A receptor has been implicated in many func-
tions.Like other 5-HT receptors,it is involved in the reg-
ulation of mood and emotional behavior,
65 and there is
evidence that 5-HT1A receptor dysfunction is involved
in depressive disorders. The agonists buspirone and
gepirone act as anxiolytics and display antidepressant-
like effects in clinical trials.
66 Human brain studies
showed that 5-HT1A receptor binding in depressed
patients is lower than in healthy subjects.
67,68 However,
there are conflicting data on this issue. Brains of non-
violent suicides had increased 5-HT1A receptor binding
in the frontal cortex in one report, whereas another
report showed no difference between suicides and con-
trols.
69,70 Furthermore,other psychiatric diseases—as well
as depression—might cause changes in 5-HT1A recep-
tors of the central nervous system.A variant of the 5-
HT1A receptor gene was found in Tourette’s patients
and, in schizophrenics, 5-HT1A receptor binding sites
were increased in the ventral prefrontal cortex.
71-73
Schizophrenics also displayed some 5-HT1A receptor
binding in the cerebellum, a brain region normally
devoid of these receptors.
74
Restraint stress downregulated 5-HT1A receptors in the
hippocampus of rats, and this effect was attributed to a
stress-induced rise in plasma glucocorticoids,the adrenal
hormones that regulate the transcription of many
genes.
75,76 The stress-induced downregulation of postsy-
naptic 5-HT1A receptors in distinct cortical areas and the
hippocampal formation, in tree shrews, could also be
attributed to high levels of glucocorticoids.
64 However,it
is interesting to note in relation to postsynaptic 5-HT1A
receptor downregulation that the effect is not exclusively
due to high glucocorticoid levels,but also to low testos-
terone.Social stress in male animals lowers testosterone
levels, and normal 5-HT1A receptor numbers can be
restored by a testosterone substitution (Figure 3).
77 It is
interesting that the number of somatodendritic 5-HT1A
autoreceptors in the dorsal raphe nucleus did not change
during chronic stress in male tree shrews,with only their
affinity being reduced.
64 This agrees with electrophysi-
ological data from the rat brain stem,which showed that
stress reduces 5-HT1A autoreceptor functioning.
78
Stress affects dopaminergic neurons
Responses of the dopamine system to stress received
particular attention because of the potential involve-
ment of this catecholamine in human psychopathologies
that are known to be exacerbated by stress,such as schiz-
ophrenia.
Groups of dopaminergic neurons are located in the mid-
brain,hypothalamus,and other regions.
4The mesocorti-
cal and mesolimbic dopamine pathways, which arise
from the ventral tegmental area, have been implicated
in emotional and memory processes.Dopaminergic cells
of the substantia nigra and the adjacent midbrain
tegmentum project to the telencephalon including the
striatum,forming the nigrostriatal pathway,which initi-
ates motor responses. Dopamine transporter (DAT)
knockout mice with high extracellular dopamine levels
were easily aroused by the mild stress of novelty.
79
However, in genetically intact animals, the persistent
stress-induced activation demonstrated in the nor-
adrenergic system has not been demonstrated in the
dopaminergic system. Under restraint stress, an initial
increase in mesolimbic dopamine release was later fol-
lowed by a decline,suggesting that repeated exposure to
the same stressor results in inhibition rather than acti-
vation of dopaminergic neurons.
80 Other data suggest
that the effects depend on the severity and controllabil-
ity of the stressor,the genetic background of the animals,
and their life history.
81 The mesocortical dopaminergic
system is obviously more stress-sensitive than the
mesolimbic and the nigrostriatal systems.
82,83
In the tree shrew model, 4 weeks of psychosocial stress
downregulated DAT in the striatum.We also found a
Pharmacological aspects
176positive correlation between locomotor activity, which
is reduced in stressed animals, and the total number of
DAT binding sites.
84 Low levels of DAT may indicate
low extracellular dopamine concentrations. In agree-
ment with these findings, social defeat in male rats also
decreased DAT binding sites in the striatum.
85
Dopamine was initially considered to convey its cellular
actions via two receptor subtypes,D1 and D2;these exert
opposing effects on the adenylate cyclase system. Five
distinct dopamine receptors have now been cloned.
36
Experiments with various knockouts could not deter-
mine where on the neurons these receptor subtypes are
located (presynaptic versus postsynaptic location).
86
However,there are indications that D1 and D5 receptors
are located postsynaptically, whereas D2,D 3, and D4
receptors are located presynaptically and postsynapti-
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Figure 3. Serotonergic nerve endings (schematic drawing, upper left) in the hippocampal formation release the neurotransmitter serotonin (gray
balls), which binds to its receptors, the serotonin-1A (5-HT1A) receptors (orange). The three pseudo-color pictures demonstrate receptor
binding in normal male tree shrews (left), in tree shrews that were submitted to chronic psychosocial stress (middle), and in stressed tree
shrews that had received testosterone as a treatment (right). Colors indicate numbers of receptors in the different regions of the hippocampal
formation: orange, high receptor numbers; yellow, moderate numbers; green, low numbers; purple, no receptors. Note that after chronic
social stress receptor numbers are decreased, but that the normal receptor number is restored following testosterone treatment.
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Stress and testosterone
Terminal of
serotonergic
neuron
Release
of serotonin
Serotonin
receptorcally,with the presynaptic receptors acting as inhibitory
autoreceptors.
87,88 In the tree shrew model,D1 receptors
were slightly increased in the striatum after 4 weeks of
psychosocial stress (Mijnster et al,unpublished observa-
tions),with a reliable increase in the prefrontal cortex,
while D2 receptors were upregulated in the hippocam-
pus.
89 Taken together, these changes in receptors and
DAT indicate impaired dopamine release after stress.
Such a deficit in dopamine release might also account for
a lack of motivation in depression.Antidepressants that
block the D2 receptor (eg,clomipramine and fluvoxam-
ine) might contribute to an improvement in motivation.
Histaminergic neurons under stress
The central nervous histamine system has been less
extensively studied with respect to stress,although it def-
initely plays an important role in the stress response.In
mammalian brains, histaminergic neurons are found
exclusively in the posterior ventral hypothalamus, but
send their fibers to all brain regions.
36,90The electrophys-
iological properties of these cells are similar to those of
the other aminergic neurons,with slow spontaneous fir-
ing,broad action potentials,and pronounced afterhyper-
polarization.
91,92 Histamine activates three types of recep-
tors whose expression varies between brain regions.
36
Histamine modulates glutamatergic neurotransmission.
H1 and H2 receptors are mainly postsynaptically located
with high densities in limbic brain regions,while H3 is a
somatodendritic autoreceptor that regulates release of
the bioamine.
91
The central histamine system is involved in many func-
tions.Activity in histaminergic neurons correlates closely
with the sleep–wake cycle,being highest when awake and
lowest during rapid-eye movement sleep.Histaminergic
neurons are also active in alarm situations and/or during
activation of the peripheral sympathetic nervous system.
91
H1 and H2 receptors modulate release of the “stress hor-
mones” corticotropin-releasing factor and vasopressin
from hypothalamic neurons,
93 while various stressors such
as dehydration or hypoglycemia stimulate histamine
release.Even handling of rats raised histamine release in
the prefrontal cortex of rats.
94Acute restraint stress stim-
ulates histamine turnover throughout the diencephalon,
whereas during chronic stress histamine turnover in the
striatum and nucleus accumbens is affected.
95A relation-
ship between histaminergic neurotransmission and emo-
tional processes is suggested by the fact that H1 receptor
antagonists and H3 receptor agonists decrease anxiety,and
because of the existence of antidepressants that block the
H1 receptor (eg,doxepin and amitriptyline).
Stress-induced neuronal remodeling 
and plasticity
The stress-induced processes described above include
changes in different compartments of cells:
•Alterations in membrane-bound proteins that occur
within seconds after the stressful stimulus (eg,confor-
mational changes in receptors, enzymes, ion channels
via stimulation of GPCRs).
• Internalization of receptors and intracellular traffick-
ing as described for β-ARs.
• Changes in large enzyme complexes involved in the
intracellular signaling cascade.
• Changes in gene transcription, which may lead to
either increased or decreased synthesis of a given pro-
tein (Figure 2).
It is possible that these dynamic processes may even
lead to morphological changes in the cells;past research
has shown that this is indeed the case.
The first proof that chronic stress induces a remodeling
of brain cells came from morphological studies on den-
drites of pyramidal neurons in area CA3 of the hip-
pocampus.Dendrites are the major regions of neuronal
synaptic contact with other neurons.Neurons with many
or highly arborized dendrites potentially have large
receptive fields (Figure 4).
The retraction of the dendrites of these neurons was
observed after chronic social stress and this effect was
attributed to the stress-induced rise in glucocorticoids.
96,97
Similar phenomena occur in pyramidal neurons in the
prefrontal cortex,where glucocorticoids also induce alter-
ations in the arborization of dendrites.
98 In the CA3 pyra-
midal neurons of the hippocampus,dendritic retraction
could be prevented by the antidepressant tianeptine,but
not by the SSRIs fluoxetine and fluvoxamine.
99 Also,
chronic social defeat in male rats induced a shrinkage of
the apical dendrites of the CA3 pyramidal neurons,and
electrophysiological measurements revealed that this phe-
nomenon was accompanied by a facilitation of action
potentials, with reduced thresholds and higher ampli-
tudes.
100 In addition,single experiences of social defeat on
two consecutive days induced similar changes in the api-
cal dendrites,with these changes persisting over 3 weeks.
In contrast to chronic daily social defeat,the arborization
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rons was increased after the double defeat paradigm.
100,101
Therefore,two severely stressful experiences had long-
lasting consequences on the morphology of neurons that
differed from those induced by daily chronic stress.Stress
was also shown to prevent long-term potentiation (LTP,a
mechanism of synaptic plasticity that is thought to be
related to memory formation) of CA neurons in the hip-
pocampus.This inhibition of LTP was observed in male
rats after only two exposures to social defeat.
101The anti-
depressant tianeptine increases the amplitude of excita-
tory postsynaptic potentials and this mechanism appears
to be related to alterations in the phosphorylation of the
N-methyl-D-aspartate (NMDA) receptor,one of the most
prominent receptors for the excitatory neurotransmitter
glutamate.
102
Synapses are often located at the tips of the spine pro-
trusions on the dendritic shafts of neurons (Figure 4).
The shape of a spine is related to the arrangement of the
actin-containing microfilaments,the cytoskeletal fibers.
103
Spines may form rapidly under the influence of synap-
tic activity.
104Activation of the NMDA receptor initiates
changes in the actin cytoskeleton that stabilize the
synaptic structure.
105 Spine formation in the neurons of
the prefrontal cortex can be induced by even minor
stimuli, such as handling the experimental animals
daily.
106 In response to an acute stress,spine density was
enhanced in the hippocampus of male rats, whereas, in
contrast,female rats showed reduced spine density.
107 It
therefore appears that spine morphology is modulated
by stress, although other factors such as sex hormones
may also have an effect on their formation.
Chronic stress and neuronal death?
There have been reports that social stress leads to cell
death in the hippocampal formation.
108 However,recent
studies using the optical dissector technique, a reliable
method for quantification of neurons within an entire
brain region, showed that stress does not affect neuron
numbers in the CA1 and CA3 areas of the hippocam-
pus.
109 Moreover,experiments using an in situ end-label-
ing technique to identify apoptotic (dying) cells showed
a significant decrease in the number of apoptotic cells
when all hippocampal areas were analyzed.
110
Although stress-induced death of principal neurons in the
hippocampus is questionable, it is clear that stress pro-
foundly affects these neurons.Their nuclear ultrastructure
changes as shown in the significant intensification in Nissl
staining.
111An electron microscopic analysis indicated that
this effect is due to increased heterochromatin formation
in the neuronal nuclei.
112The physiological role of these
changes is unknown,but one may speculate that they are
accompanied by alterations in gene transcription.Recent
tree shrew studies showed that chronic psychosocial stress
reduced the expression of certain genes that are related to
the shape of neurons and other brain cells.
113 In the brains
of adult rats that had been prenatally stressed through the
stressful treatment of the pregnant dams, expression of
genes associated with excitatory neurotransmission and
mechanisms of neurotransmitter release were significantly
altered.
114 Furthermore,a large group of genes in the hip-
pocampus has been shown to be differentially expressed
after glucocorticoid treatment.
76
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Figure 4. Schematic drawing of a CA3 pyramidal neuron plus its den-
drites. Note the small soma in comparison to the highly
arborized apical and basal dendrites. Inset: dendritic shafts can
build up protrusions (spines) that form synapses with axons or
dendrites from other neurons. Synapses are sites of signal
transmission between neurons. Formation and disappearance
of spines are regulated by many factors such as gonadal hor-
mones. Chronic psychosocial stress reduces the arborization of
the apical dendrites, thus reducing the surface area of the neu-
ron with the consequence that the neuron receives less infor-
mation from other neurons (see text for details).
Apical
dentrites
Basal
dentrites
Soma
Axon
Spine
SynapseConclusions and further directions
Despite extensive preclinical and clinical investigations,
the exact neurobiological processes leading to depres-
sion and the mechanisms responsible for the therapeu-
tic effects of antidepressant drugs are still not completely
understood.Antidepressants are presently believed to
exert their primary biochemical effects by readjusting
aberrant intrasynaptic concentrations of neuromodula-
tors such as 5-HT. However, the limitations of current
antidepressant medications,such as the time delay for a
full therapeutic response,the substantial number of non-
responders, and bothersome side effects merit a full
exploration of all plausible agents with novel antide-
pressant mechanisms of action.
Recent preclinical and clinical studies suggest that major
depressive disorders are associated with cellular
resilience and an impairment of synaptic and structural
plasticity, and that antidepressant medications may act
by correcting this dysfunction.Although this concept is
still in its infancy, it has increasingly attracted research
efforts that may result in new treatment strategies for
the etiopathophysiology of psychiatric disorders,such as
major depression. ❏
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Consecuencias celulares del estrés y la 
depresión
Se sabe que el estrés activa distintos circuitos neu-
ronales en el cerebro e induce múltiples cambios a
nivel celular incluyendo alteraciones en las estruc-
turas neuronales. A partir de las observaciones clí-
nicas, que indican que a menudo el estrés precipita
una enfermedad depresiva, el estrés psicosocial cró-
nico sirve como modelo experimental para evaluar
las alteraciones celulares y moleculares asociadas
con las consecuencias de la depresión mayor.
Actualmente se cree que los antidepresivos ejercen
sus efectos bioquímicos primarios mediante un rea-
juste de las concentraciones intrasinápticas abe-
rrantes de neurotransmisores, como la serotonina
y la noradrenalina, lo que sugiere que el desbalance
dentro del sistema monoaminérgico contribuye al
trastorno (hipótesis monoaminérgica de la depre-
sión). Aquí se revisan los resultados que contribu-
yen a nuestra comprensión acerca de las conse-
cuencias del estrés sobre los procesos celulares, con
particular atención a los sistemas monoaminérgicos
y los cambios estructurales de las áreas cerebrales
blanco de las neuronas monoaminérgicas. 
Conséquences cellulaires du stress et 
dépression
Il est reconnu que le stress met en jeu des circuits
neuronaux distincts dans le cerveau et induit de
nombreux changements au niveau cellulaire, y com-
pris des altérations des structures neuronales. Sur la
base d’observations cliniques ayant montré que le
stress déclenchait souvent une maladie dépressive,
le stress psychosocial chronique peut être pris
comme modèle expérimental pour évaluer les alté-
rations moléculaires et cellulaires associées aux con-
séquences d’une dépression majeure. Selon les con-
ceptions actuelles, les antidépresseurs exercent leur
effet biochimique primaire en réajustant les con-
centrations intrasynaptiques aberrantes des neuro-
transmetteurs, telles la sérotonine et la noradréna-
line. Ceci suggère que les déséquilibres des systèmes
monoaminergiques sont impliqués dans la genèse
de la dépression (hypothèse monoaminergique).
Cet article passe en revue les résultats qui contri-
buent à notre compréhension des conséquences du
stress sur les processus cellulaires, avec une atten-
tion particulière sur les systèmes monoaminergi-
ques et les changements structurels des régions
cérébrales cibles des neurones monoaminergiques.Cellular consequences of stress and depression - Fuchs and Flügge Dialogues in Clinical Neuroscience - Vol 6 . No.2 . 2004
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